Click on a filter below to refine your search. Remove a filter to broaden your search.
Did you mean: eformes
Model includes demographic information, brain imaging test results, and genetic biomarkers
Grounds insufficient to offer aducanumab for moderate, advanced Alzheimer dementia or patients without biomarker evidence of brain ß-amyloid
In randomized, double-blind trial, no difference seen in scores for agitated behaviors at 12 weeks with mirtazapine versus placebo